✦ LIBER ✦

Effects of tyrosine kinase inhibitors alone or in combination with vaccine on tumor-infiltrating myeloid cells

✍ Scribed by Renee N Donahue,Italia Grenga,Jeffrey Schlom…

Book ID: 126381215
Publisher: Springer (Biomed Central Ltd.)
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 1
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-1-S1-P183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Lovastatin Alone or Combined

Effects of Lovastatin Alone or Combined with Irradiation on Tumor Cells in Vitro and in Vivo

✍ Dorota Gabry's; Annegret Dörfler; Ala Yaromina; Franziska Hessel; Mechthild Krau 📂 Article 📅 2008 🏛 Springer 🌐 German ⚖ 344 KB

6632 Characterisation of the response of

6632 Characterisation of the response of pancreatic cancer cells to treatment with chemotherapeutic agents alone and in combination with tyrosine kinase inhibitors

✍ Sheikh, R.; O'connor, R.; Walsh, N.; Clynes, M.; Mcdermott, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Biological effect of tyrosine kinase inh

Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses

✍ Y. TAKEUCHI; Y. FUJINO; K. FUKUSHIMA; M. WATANABE; T. NAKAGAWA; K. OHNO; N. SASA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

The effect of interleukin 11 on thromboc

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

✍ Ahmed Aribi; Hagop Kantarjian; Charles Koller; Deborah Thomas; Stefan Faderl; Gu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Effects of the Hedgehog Inhibitor GDC-04

Effects of the Hedgehog Inhibitor GDC-0449, Alone or in Combination with Dasatinib, on BCR-ABL-Positive Leukemia Cells

✍ Okabe, Seiichi; Tauchi, Tetsuzo; Tanaka, Yuko; Katagiri, Seiichiro; Ohyashiki, K 📂 Article 📅 2012 🏛 Mary Ann Liebert 🌐 English ⚖ 680 KB

Antiproliferative and proapoptotic activ

Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells

✍ Guido Bocci; Anna Fioravanti; Concettina La Motta; Paola Orlandi; Bastianina Can 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 457 KB